U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C16H16ClN3O3S
Molecular Weight 365.835
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of INDAPAMIDE

SMILES

CC1CC2=C(C=CC=C2)N1NC(=O)C3=CC=C(Cl)C(=C3)S(N)(=O)=O

InChI

InChIKey=NDDAHWYSQHTHNT-UHFFFAOYSA-N
InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)

HIDE SMILES / InChI
Molecular Formula C16H16ClN3O3S
Molecular Weight 365.835
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:05:45 UTC 2023
Edited
by admin
on Fri Dec 15 17:05:45 UTC 2023
Record UNII
F089I0511L
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
INDAPAMIDE
EP   INN   JAN   MART.   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF   WHO-DD  
USAN   INN  
Official Name English
IPAMIX
Brand Name English
INDAPAMIDE [USAN]
Common Name English
INDAPAMIDE [JAN]
Common Name English
NORANAT
Brand Name English
INDAPAMIDE [MI]
Common Name English
SE-1520
Code English
NSC-757075
Code English
Indapamide [WHO-DD]
Common Name English
indapamide [INN]
Common Name English
BAJATEN
Brand Name English
NATRILIX
Brand Name English
KYD-041
Code English
INDAPAMIDE [VANDF]
Common Name English
TANDIX
Common Name English
FLUDEX
Brand Name English
INDAMOL
Brand Name English
FLUBEST
Brand Name English
4-Chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide
Systematic Name English
TERTENSIF
Brand Name English
INDAPAMIDE [EP IMPURITY]
Common Name English
ARIFON
Brand Name English
INDAFLEX
Brand Name English
NATRIX
Brand Name English
INDAPAMIDE [USP MONOGRAPH]
Common Name English
FLUPAMID
Brand Name English
DAMIDE
Brand Name English
LOZOL
Brand Name English
INDAPAMIDE [MART.]
Common Name English
INDAPAMIDE [EP MONOGRAPH]
Common Name English
LORVAS
Brand Name English
FLUDIN
Brand Name English
INDAMIDE
Brand Name English
INDAPAMIDE [USP-RS]
Common Name English
BR-1015 component Indapamide
Common Name English
INDAPAMIDE [ORANGE BOOK]
Common Name English
S-1520
Code English
VEROXIL
Brand Name English
Classification Tree Code System Code
NCI_THESAURUS C49185
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
NDF-RT N0000175420
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
WHO-VATC QC03BA11
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
WHO-ATC C03BA11
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
NDF-RT N0000175359
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
LIVERTOX 503
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
WHO-ATC C09BX01
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
WHO-ATC C10BX13
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
WHO-VATC QC09BX01
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
Code System Code Type Description
DRUG CENTRAL
1433
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
ECHA (EC/EINECS)
248-012-7
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
WIKIPEDIA
INDAPAMIDE
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
MERCK INDEX
m6245
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY Merck Index
MESH
D007190
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
IUPHAR
7203
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
PUBCHEM
3702
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
FDA UNII
F089I0511L
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
EPA CompTox
DTXSID7044633
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
DAILYMED
F089I0511L
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
LACTMED
Indapamide
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
ChEMBL
CHEMBL406
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
RS_ITEM_NUM
1338801
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
NSC
757075
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
CHEBI
5893
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
EVMPD
SUB08169MIG
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
NCI_THESAURUS
C29119
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
CAS
26807-65-8
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
INN
3333
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
RXCUI
5764
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY RxNorm
SMS_ID
100000092651
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
DRUG BANK
DB00808
Created by admin on Fri Dec 15 17:05:45 UTC 2023 , Edited by admin on Fri Dec 15 17:05:45 UTC 2023
PRIMARY
Related Record Type Details
Structure of INDAPAMIDE, (R)-
ENANTIOMER -> RACEMATE
Structure of INDAPAMIDE, (S)-
ENANTIOMER -> RACEMATE
Structure of INDAPAMIDE
EXCRETED UNCHANGED
Lozol is an extensively metabolized drug, with only about 7% of the total dose administered, recovered in the urine as unchanged drug during the first 48 hours after administration.
Structure of INDAPAMIDE
BASIS OF STRENGTH->SUBSTANCE
ASSAY (HPLC)
EP
Structure of INDAPAMIDE HEMIHYDRATE
SALT/SOLVATE -> PARENT
PLASMA PROTEIN FRACTION (HUMAN)
BINDER->LIGAND
From 71 to 79% of the Lozol in plasma is reversibly bound to plasma proteins.
REVERSIBLE
Structure of INDAPAMIDE
BASIS OF STRENGTH->SUBSTANCE
ASSAY (HPLC)
USP
Structure of INDAPAMIDE HEMIHYDRATE
SOLVATE->ANHYDROUS
SOLUTE CARRIER FAMILY 12 MEMBER 3
TARGET -> INHIBITOR
indapamide has both diuretic and vasodilator properties. A low urinary excretion and specific accumulation into arterial smooth muscle of this lipophilic molecule may provide a rationale for this dual activity.
OAT-3
TRANSPORTER -> INHIBITOR
Related Record Type Details
Structure of METHYL 4-CHLORO-3-SULFAMOYLBENZOATE
METABOLITE -> PARENT
Related Record Type Details
Structure of DEHYDROINDAPAMIDE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 2-METHYLINDOLINE
IMPURITY -> PARENT
Structure of 1-AMINO-2-METHYLINDOLINE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of DEHYDROINDAPAMIDE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 2-METHYL-1-NITROSO-2,3-DIHYDRO-1H-INDOLE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 2-METHYL-1-NITROSO-2,3-DIHYDRO-1H-INDOLE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 2-METHYLINDOLIN-1-AMINE HYDROCHLORIDE
IMPURITY -> PARENT
Related Record Type Details
Structure of INDAPAMIDE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
Tmax PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966